$FIGS

Figs (NYSE:FIGS) Delivers Impressive Q2 CY2026, Stock Jumps 25.1%

Figs (NYSE:FIGS) reported Q2 CY2026 revenue of $196.6 million, up 28.8% year over year and 5.6% above Wall Street estimates, and EPS of $0.15 versus $0.04 a year earlier. Analysts expect revenue growth of 6.1% over the next 12 months. The stock rose 25.1% to $14.07 after results.

Original reporting
Published Aug 6, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Figs (NYSE:FIGS) Delivers Impressive Q2 CY2026, Stock Jumps 25.1% — source image
Decision brief

The 30-second read

$FIGSBullishMed
01

Why it matters

Traders can use the beat and margin expansion to reassess near-term earnings power, while the stated consensus deceleration in revenue and EPS contraction may influence positioning into the next earnings cycle.

02

Market read

A company-specific earnings beat with margin improvement drove a large same-day move, but consensus expects slower growth and lower EPS over the next 12 months.

03

What to watch

The article highlights operating margin and EPS, but does not detail guidance drivers, inventory, or cash flow quality, which could determine whether the margin gains are sustainable.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session reaction to Q2 results, stock jumped 25.1% immediately after reporting

Background

The piece summarizes Figs Q2 CY2026 results versus Wall Street estimates and provides a forward-looking consensus snapshot for revenue and EPS.

Company-level read

Ticker impact

$FIGSBullishMedium confidence
Context

Figs reported Q2 revenue up 28.8% year over year to $196.6 million, beating estimates by 5.6%, and shares jumped 25.1% after the print.

Expected impact

Near-term upside bias likely persists given the reported beat and margin expansion, but the forward EPS decline expectation may cap follow-through.

Evidence & confidence

The newest concrete facts are the Q2 revenue/EPS beats, operating margin expansion, and the immediate 25.1% stock jump; however, the forward EPS shrink forecast introduces a counterweight that can limit sustained momentum.

Market effects

Signals improving profitability trajectory for a consumer discretionary apparel/healthwear name, but forward EPS expectations suggest demand normalization risk.

No specific regional spillover mentioned.

No global macro or international demand drivers cited.

Counterpoint

The forward view calls for full-year EPS to shrink 14.1%, so the rally may be over-discounting a temporary margin improvement rather than durable earnings growth.

Key entities

  • Figs

    Reported Q2 revenue and EPS beats, with operating margin expansion, and the stock jumped 25.1% immediately after results.

Related articles

$FIGSHighAI 9/10

FIGS (FIGS) Q2 2026 Earnings Call Transcript

FIGS, Inc. (FIGS) reported Q2 2026 net revenues of $196.6 million, up 28.8%, driven by higher order volume and record average order values. Scrubwear revenue rose 26.5% to $161.2 million. Gross margin was 75.2% and net income $28.4 million. The company raised FY2026 net revenue guidance to about 20% growth and EBITDA margin to 14.8% to 15.0%.

$FIGSMedAI 8/10

FIGS Stock Soars After Earnings Beat And Upgraded Outlook

FIGS Inc. (NYSE: FIGS) shares rose about 28.7% in a week after a Q2 earnings beat and an upgraded FY26 outlook, according to the article. Q2 results included EPS $0.15 vs $0.07 and revenue up 29% to $196.6M, with gross margin 66.6% and adjusted EBITDA margin 18.6%. FY26 guidance was raised to about 20% revenue growth and 14.8% to 15% EBITDA margin.

$FIGSHighAI 9/10

FIGS Q2 Earnings Call Highlights

FIGS (NYSE:FIGS) reported Q2 results and an earnings call update. International revenue rose 67% to $37.9M and U.S. revenue grew 22% to $158.7M. Gross margin increased to 75.2% with a $15.4M tariff refund benefit. Net income was $28.4M, or $0.15/share. FIGS raised FY2026 revenue growth to ~20% and operating margin to ~10.8%, and repurchased about $24M of shares.

$FIGSHighAI 9/10

FIGS Stock Jumped 27% on Its Q2 Beat. The Raised Guide Did the Real Work.

FIGS (FIGS) shares rose about 27% on Aug. 7 after Q2 results beat estimates and management raised full-year guidance. Q2 revenue was $196.6M (+29% YoY) and EPS was $0.15 vs $0.07 consensus. Gross margin hit 75.2% but included a one-time tariff refund; core margin improved. Full-year growth guidance lifted to ~20% from 14% to 16%, plus a $100M buyback authorization.

$FIGSMedAI 8/10

FIGS, Inc. Lifts Outlook Amid Robust Growth

FIGS, Inc. (FIGS) reported Q2 results and lifted full-year revenue growth guidance to about 20%. Net revenues rose 29% to $196.6M, with gross margin up 820 bps to 75.2% and operating margin to 17.9%. Management cited $20.5M tariff refunds and raised 2026 operating margin and adjusted EBITDA outlooks, while noting Q3 margin pressure from a Jordan import hold and airfreight.

$FIGSHighAI 8/10

Why Figs Stock Popped Today

Figs (NYSE: FIGS) shares rose after the medical apparel company reported Q2 results above expectations. Net revenue increased 28.8% to $196.6 million, with active customers up 13.2% to 3.1 million. Gross margin rose to 75.2% and net income rose to $28.4 million, or $0.15 per share. Figs raised its 2026 revenue growth outlook to about 20% and increased its buyback by $100 million.